Washington Trust’s BioNTech BNTX Stock Holding History

Washington Trust’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-27	Closed	-$2.46K	–	306
2025 Q1	$2.46K	Hold	27	–	–	﹤0.01%	711
2024 Q4	$3.08K	Hold	27	–	–	﹤0.01%	779
2024 Q3	$3.21K	Hold	27	–	–	﹤0.01%	775
2024 Q2	$2.17K	Hold	27	–	–	﹤0.01%	811
2024 Q1	$2.49K	Hold	27	–	–	﹤0.01%	803
2023 Q4	$2.85K	Hold	27	–	–	﹤0.01%	773
2023 Q3	$2.93K	Hold	27	–	–	﹤0.01%	736
2023 Q2	$2.91K	Hold	27	–	–	﹤0.01%	753
2023 Q1	$3.36K	Hold	27	–	–	﹤0.01%	761
2022 Q4	$4.06K	Hold	27	–	–	﹤0.01%	745
2022 Q3	$4K	Hold	27	–	–	﹤0.01%	731
2022 Q2	$4K	Hold	27	–	–	﹤0.01%	730
2022 Q1	$5K	Buy	+27	New	+$4.54K	﹤0.01%	731

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Washington Trust's BNTX Position: Q2 2025 in Review

Washington Trust sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 27 shares — an estimated $2.46K sold.

Washington Trust first reported a position in BNTX in Q1 2022 and held it in 13 quarters. The position peaked at $5K in Q1 2022. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

Washington Trust reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
Washington Trust sold 27 BioNTech shares in Q2 2025, an estimated $2.46K.
Washington Trust first reported a position in BioNTech in Q1 2022 and held it in 13 quarters.
Washington Trust's BioNTech position peaked at $5K in Q1 2022.
258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.